Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial
暂无分享,去创建一个
T. Yoshikawa | K. Muro | T. Asakawa | A. Hosokawa | T. Nishina | K. Shitara | K. Fujitani | H. Hara | S. Kawakami